STX17 and Cognitive impairment: In the probe trial, the mice in the Meth-treated group spent a significantly lower percentage of time in the target quadrant, whereas overexpression of Stx17 in the hippocampus partially rescued the Meth-induced cognitive impairment, resulting in more time spent in the target quadrant compared with that of the Meth group (Fig. 1G).